Innovative cancer medicine toripalimab has become the first biopharmaceutical drug from China to be approved by America's FDA The US is continuing to struggle through a drug shortage crisis, with ...
In 2018, Hutchmed’s fruquintinib became the first domestically developed drug for a major cancer type to be approved in China. Five years later, the FDA has signed off on the VEGF inhibitor for ...
(Reuters) - Eli Lilly said on Friday the U.S. Food and Drug Administration (FDA) gave a second approval for its drug Jaypirca ...
Nov 15 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb's (BMY.N) lung cancer drug that was acquired as part of the company's $4.1 billion buyout of ...
An FDA panel is urging Acrotech Biopharma to accelerate research into the efficacy of two blood cancer drugs brought to market via the agency's accelerated approval pathway. The FDA's Oncologic ...
A year after the FDA found shredded quality documents at an Intas Pharmaceuticals drug manufacturing facility in India, Intas' parent company Accord Healthcare resumed making cisplatin, which has ...
The Food and Drug Administration on Wednesday approved a new targeted therapy for metastatic colon cancer, granting an OK to Furzaqla from Takeda. The drug is cleared for adults with previously ...
Nov 16 (Reuters) - The U.S. Food and Drug Administration on Thursday approved AstraZeneca's (AZN.L) Truqap in combination with an older drug, providing another treatment option for patients with ...
House Republicans on Friday launched an investigation into the Food and Drug Administration's handling of the long-term prescription drug and pharmaceutical product shortage. Oversight Chairman ...
An innovative biopharmaceutical medicine from China has been approved by the US Food and Drug Administration (FDA) to treat cancer, as the US turns to China to solve its cancer drug shortages.
"The FDA is failing to ensure vitally important pharmaceuticals remain on pharmacy shelves," wrote Comer and McClain in a letter to Califf. "It is of vital importance that the FDA monitor and ...
